Bioscience is a fundamentally important sector for the UK’s health and wealth. Last year we published our report Celebrating UK bioscience: unravelling the stories behind UK bioscience success, which details just some examples of UK bioscience success. 

The antibody-humanising technologies developed in the UK and which were the foundation of Humira’s success have also been used in the development of over half of marketed antibody therapies today, including multiple sclerosis drug Lemtrada.

Multiple Sclerosis

Download the series of infographics here

Keep an eye out for the next phase of our Celebrate project, launching at this year’s UK Bioscience Forum on 20 October…